By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – PGXL Labs today announced a partnership for the use of AutoGenomics' Infiniti Analyzer for several personal medicine applications.

PGXL plans to use the Infiniti Warfarin assay and the CYP450 assay, both of which have been cleared by the US Food and Drug Administration, as well as the Infiniti KRAS-BRAF test, it said.

AutoGenomics' Infiniti Analyzer is a microarray-based molecular diagnostics platform for measuring multiple signals from clinical samples.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.